Clinical trials
Terminated Lymphoma, T-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 38 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| Dana-Farber Cancer Institute | 2 |
| Fred Hutchinson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| University of Alabama at Birmingham | 2 |
| miRagen Therapeutics, Inc. | 2 |
| Agios Pharmaceuticals, Inc. | 1 |
| Alaunos Therapeutics | 1 |
| Autolus Limited | 1 |
| Beijing Boren Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell | 38 |
| Lymphoma | 16 |
| Lymphoma, Non-Hodgkin | 12 |
| Lymphoma, Large B-Cell, Diffuse | 7 |
| Lymphoma, Large-Cell, Anaplastic | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Lymphoma, B-Cell | 6 |
| Hodgkin Disease | 5 |
| Immunoblastic Lymphadenopathy | 5 |
| Lymphoma, T-Cell, Peripheral | 5 |
Trials
Showing 51 to 38 of 38. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.